関連する実験動画
Updated: Sep 9, 2025
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
444
双極性障害の患者における認知障害に対するNMDA受容体調節治療:記述的レビュー
Rahim Badrfam1, Atefeh Zandifar2
1Department of Psychosomatic Medicine, Shariati Hospital, Alborz University of Medical Sciences, Karaj, Alborz, Iran; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Alborz, Iran.
General hospital psychiatry
|August 31, 2025
まとめ
N-メチル-d-アスパルテート受容体 (NMDAR) は,双極性障害の認知障害の改善に有望であることが示されています. これらの薬剤の有効性と安全性を確認するには,さらなる研究とより長い試験が必要です.
科学分野:
- 神経科学
- 精神科
- 薬理学について
背景:
- 認知障害は双極性障害の主な課題であり,日常の機能と治療結果に影響します.
- 現在の双極性障害の治療法では 認知機能が改善されず 悪化さえします
- グルタマタージック系,特にN-メチル-d-アスパルテート受容体 (NMDARs) は,認知障害に関与しています.
研究 の 目的:
- 双極性障害における認知機能の強化のためのNMDAR調節に関する研究をレビューする.
- NMDAR調節剤の動物研究と初期臨床試験の発見を強調する.
主な方法:
- PubMedとGoogle Scholarを使って体系的な文献検索が行われました.
- PRISMAのガイドラインに従って,双極性障害における認知障害に対するNMDARアンタゴニストに関する関連する研究を特定しました.
主要な成果:
- メマンタンは,治療抵抗性双極性障害を含む様々な状態において,補足療法として認知機能の改善を示した.
- ケタミン注入は 双極性障害の患者の処理速度と言語学習に 利点を示しました
結論:
- NMDAR調節剤は双極性障害の認知機能の改善に有意な可能性を示しています.
- NMDARアンタゴニストの長期的な有効性と安全性を評価するには,さらなる多センター試験が必要である.
- NMDARをターゲットにすることで,注意力,実行機能,記憶障害などの持続的な認知障害に対処することができます.
関連する概念動画
01:24Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
01:23Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:28Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
01:03Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K